The ExoVasc® PEARS provides an alternative to aortic root replacement. A personalised, custom-made external support is made to exactly match the patient’s aorta.
Learn more
Exstent Limited and LeviBio are exhibiting at the first ever World Summit for Pediatric and Congenital Heart Surgery, held in Bologna, Italy on June 5
Petr Fila presented on PEARS in Aortic Root Aneurysm at the Vienna Interdisciplinary Symposium on Aortic Repair (VISAR 2024), which was held May 13-14, 2024,
CKTCH Brno (Centrum kardiovaskulární a transplantační chirurgie) completed its 60th ExoVasc® PEARS implantation in April 2024. Petr Fila, Deputy Head at CKTCH commented: “We are thrilled
Ana Redondo and Conal Austin have released the first published paper on the Ross PEARS application entitled ‘Our 7-year experience supporting the Ross autograft with
Exstent’s new Australian Distributor and Sponsor, BTC Cardio Pty, Australia is sponsoring the Marfan and Aortopathy conference on Saturday 20 April at The Prince Charles
A report on the Ross-PEARS case in Genoa performed by Dr Michielon and Dr Conal Austin on 4 March 2024 was broadcast by the Liguria
Exstent Ltd, developer and manufacturer of the ExoVasc® Personalised External Aortic Root Support (PEARS), has just announced that 1,000 patients have received the device. The
The team at Royal Victoria Hospital Belfast has won a prize at SCTS 2024 for its poster ‘A Case Study: Application of Personalised External Aortic
Ana Redondo has had an abstract on paediatric Ross PEARS accepted for the AEPC (Association for European Paediatric and Congenital Cardiology) Meeting, which will be
Multiple presentations will be given on ExoVasc PEARS at the AATS Aortic Symposium 2024, which runs 24 to 26 April 2024 in New York. Prof
We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.